HealthCare News: Teen Mental Health Rates, New Pain Management Drugs and Overdose Awareness Month
Haven Health Management
Advancing recovery through evidence-based care nationwide.
One-Third of U.S. Teens Now Receiving Mental Health Support, SAMHSA Study Shows
A recent SAMHSA study reveals that nearly one-third of U.S. teens aged 12 to 17 received mental health support in 2023, indicating a significant rise in awareness and treatment.
Join us in remembering and honoring the lives lost as we raise awareness to prevent overdose deaths.
FDA Greenlights Review of Vertex’s Suzetrigine for Severe Acute Pain
A new pain management drug from Vertex Pharmaceuticals, has been granted FDA priority review. This drug could revolutionize the treatment of acute pain without the risks associated with opioids.
New Study Reveals Reasons Behind Doctors’ Hesitation in Prescribing Addiction Treatments
Uncover the institutional and social challenges stopping physicians from providing effective addiction treatment.